Patient NAME : Mrs.
ANJALI HALDER Barcode NO : 14111427
Age/Gender : 83 Y/Female Sample Collected ON : 09/Sep/2025
LabNo : 012509092142 Sample Received ON : 09/Sep/2025
Referred BY :Dr. s k das (md) Report Generated ON : 09/Sep/2025
CLIENT CODE :WBCL/NAPP/SML Sample STATUS : Final Approved
Refer Lab/Hosp : Other Info :
Lab Address :AS 130, Block-H, R M Road, Kol: 157
DEPARTMENT OF HEMATOLOGY
Test Name Value Unit Bio Ref.Interval
CBC
Erythrocytes
Haemoglobin 12.5 g/dL 12-15
(Method:Spectrophotometry) (Sample:EDTA )
RBC Count 4.2 10^12/L 3.8-4.5
(Method:Electrical Impedance) (Sample:EDTA )
PCV (Packed Cell Volume) 36.5 % 36-46
(Method:Electrical Impedance) (Sample:EDTA )
MCV (Mean Corpuscular Volume) 86.9 fl 83-101
(Method:Calculated) (Sample:EDTA )
MCH (Mean Corpuscular Hemoglobin) 29.76 pg 27-32
(Method:Calculated) (Sample:EDTA )
MCHC (Mean Corpuscular Hemoglobin 34.2 g/dl 31.5-34.5
Concentration)
(Method:Calculated) (Sample:EDTA )
RDW-CV 15.1 % 11.6-14.0
(Method:Calculated) (Sample:EDTA )
Leucocytes
WBC Count,Total 5,700 cells/μl 4000-10000
(Method:Flow cytometry) (Sample:EDTA )
Differential Leucocyte Count
Neutrophils 85 % 40-80
(Method:Leishman Stain - Light Microscopy) (Sample:EDTA )
Lymphocytes 10 % 20-40
(Method:Leishman Stain - Light Microscopy) (Sample:EDTA )
Monocytes 2 % 2-10
(Method:Leishman Stain - Light Microscopy) (Sample:EDTA )
Eosinophils 3 % 1-6
(Method:Leishman Stain - Light Microscopy) (Sample:EDTA )
Basophils 0 % 0-2
(Method:Leishman Stain - Light Microscopy) (Sample:EDTA )
Absolute Neutrophil Count 4,845 Cells/µL 2000-7000
(Method:Leishman Stain - Light Microscopy) (Sample:EDTA )
Absolute Lymphocyte Count 570 Cells/µL 1000-3000
(Method:Leishman Stain - Light Microscopy) (Sample:EDTA )
Absolute Monocyte Count 114 Cells/µL 200 - 1000
(Method:Leishman Stain - Light Microscopy) (Sample:EDTA )
Absolute Eosinophil Count 171 cells/µL 20-500
(Method:Leishman Stain - Light Microscopy) (Sample:EDTA )
Page 1 of 5
Patient NAME : Mrs.ANJALI HALDER Barcode NO : 14111427
Age/Gender : 83 Y/Female Sample Collected ON : 09/Sep/2025
LabNo : 012509092142 Sample Received ON : 09/Sep/2025
Referred BY :Dr. s k das (md) Report Generated ON : 09/Sep/2025
CLIENT CODE :WBCL/NAPP/SML Sample STATUS : Final Approved
Refer Lab/Hosp : Other Info :
Lab Address :AS 130, Block-H, R M Road, Kol: 157
DEPARTMENT OF HEMATOLOGY
Test Name Value Unit Bio Ref.Interval
Absolute Basophil Count 0 Cells/µL <200
(Method:Leishman Stain - Light Microscopy) (Sample:EDTA )
Thrombocytes
Platelet Count 180 10^9/L 150-410
(Method:Electrical Impedance ) (Sample:EDTA )
Erythrocyte Sedimentation Rate
ESR 15 mm in 1hr ≤35
(Method:Westergren method) (Sample:EDTA )
Morphology
RBC Morphology Normocytic and Normochromic.
(Method:Microscopic) (Sample:EDTA )
WBC Morphology Neutrophilia
(Method:Microscopic) (Sample:EDTA )
Platelets Adequate.
(Method:Microscopy) (Sample:EDTA )
Please clinically correlate. Partial reproduction of test reports is strictly prohibited.
The reports are strictly for the use of medical practitioners and are not medical diagnosis.
Note:
All the reference ranges have been cited from Dacie and Lewis Practical Hematology, Eleventh edition. The value of the reference ranges are approximated considering wide variation across
different age groups, genders and geographic location. All values are to be interpreted in the context of clinical findings of the patient.
As per the recommendation of International council for Standardization in Hematology, the differential leucocyte counts are additionally being reported as absolute numbers of each cell in per
unit volume of blood.
Page 2 of 5
Patient NAME : Mrs.ANJALI HALDER Barcode NO : 14111427
Age/Gender : 83 Y/Female Sample Collected ON : 09/Sep/2025
LabNo : 012509092142 Sample Received ON : 09/Sep/2025
Referred BY :Dr. s k das (md) Report Generated ON : 09/Sep/2025
CLIENT CODE :WBCL/NAPP/SML Sample STATUS : Final Approved
Refer Lab/Hosp : Other Info :
Lab Address :AS 130, Block-H, R M Road, Kol: 157
DEPARTMENT OF BIOCHEMISTRY
Test Name Value Unit Bio Ref.Interval
Glucose - Fasting 126 mg/dL Adults:74-106
(Method:Hexokinase) (Sample:Fluoride Plasma) Children:60-100
Pre-Diabetic: 111 - 125
Diabetic: ≥ 126
Please clinically correlate. Partial reproduction of test reports is strictly prohibited.
The reports are strictly for the use of medical practitioners and are not medical diagnosis.
Comments:
Glucose is a reducing monosaccharide that serves as the principal fuel for all tissues. It enters the cell through the influence of insulin and undergoes a series of chemical reactions to produce
energy. Lack of insulin or resistance to its action at the cellular level causes diabetes. Therefore, in diabetes mellitus, the blood glucose levels are very high. Hyperglycemia is also noted in
gestational diabetes during pregnancy and may be found in pancreatic disease, pituitary, and adrenal disorders. A decreased level of blood glucose and hypoglycemia is often associated with
starvation, hyperinsulinemia, and in those who are taking high insulin doses for therapy. Clinical diagnosis should not be made on the findings of a single test result but should integrate both
clinical and laboratory data.
Note: For pre-hyperglycemic results please repeat the test with fresh samples for 2 consecutive days recommended.
Reference: www.who.int/diabetes/publications/
Creatinine 0.65 mg/dl 0.51– 0.95
(Method:MODIFIED JAFFE) (Sample:Serum)
Please clinically correlate. Partial reproduction of test reports is strictly prohibited.
The reports are strictly for the use of medical practitioners and are not medical diagnosis.
Comments:
Creatinine is a catabolic end product of creatine. The amount produced each day is related to muscle mass. Creatinine is freely filtered by the glomerulus,(small amounts are reabsorbed and secreted by renal
tubules). Creatinine is measured for the assessment of kidney function(impaired renal perfusion, loss of functioning nephrons) and in monitoring renal dialysis. The method commonly used for estimating
Creatinine makes use of Jaffe’s reaction with an alkaline picrate reagent.
Page 3 of 5
Patient NAME : Mrs.ANJALI HALDER Barcode NO : 14111427
Age/Gender : 83 Y/Female Sample Collected ON : 09/Sep/2025
LabNo : 012509092142 Sample Received ON : 09/Sep/2025
Referred BY :Dr. s k das (md) Report Generated ON : 09/Sep/2025
CLIENT CODE :WBCL/NAPP/SML Sample STATUS : Final Approved
Refer Lab/Hosp : Other Info :
Lab Address :AS 130, Block-H, R M Road, Kol: 157
DEPARTMENT OF BIOCHEMISTRY
Test Name Value Unit Bio Ref.Interval
Liver Function Test (LFT)
Bilirubin Total 1.21 mg/dL Adults- 0.3-1.2
(Method:DPD) (Sample:Serum) Children (0-1 Day) 1.4-8.7
Children (1-2 Day) 3.4-11.5
Children (3-5 Day) 1.5-12.0
Bilirubin Direct 0.22 mg/dL <0.2
(Method:DPD) (Sample:Serum)
Bilirubin Indirect 0.99 mg/dl 0.2-0.8
(Method:Calculated) (Sample:Serum)
ALT/SGPT 22 U/L <35
(Method:IFCC ) (Sample:Serum)
AST/SGOT 39 U/L <35
(Method:IFCC ) (Sample:Serum)
SGOT/SGPT Ratio 1.77
Alkaline Phosphatase (ALP) 112 U/L 30 - 120
(Method:IFCC ) (Sample:Serum)
Protein Total 8.2 g/dL Newborn: 4.1-6.3
(Method:Biuret) (Sample:Serum) Children:5.7-8.0
Adults: 6.6-8.3
Albumin 4.1 g/dL 3.5 - 5.2
(Method:BCG) (Sample:Serum)
Globulin 4.1 g/dL 2.3 - 3.9
(Method:Calculated) (Sample:Serum)
Albumin / Globulin Ratio 1.0 -
(Method:Calculated) (Sample:Serum)
Please clinically correlate. Partial reproduction of test reports is strictly prohibited.
The reports are strictly for the use of medical practitioners and are not medical diagnosis.
Comments:
Liver function tests (LFTs), also known as liver panel or hepatic function tests, are a group of blood tests used to assess the health and function of the liver. These tests provide valuable information about the liver's ability to perform its
essential functions, including metabolizing nutrients, filtering toxins, and producing proteins necessary for various bodily functions.
Page 4 of 5
Patient NAME : Mrs.ANJALI HALDER Barcode NO : 14111427
Age/Gender : 83 Y/Female Sample Collected ON : 09/Sep/2025
LabNo : 012509092142 Sample Received ON : 09/Sep/2025
Referred BY :Dr. s k das (md) Report Generated ON : 09/Sep/2025
CLIENT CODE :WBCL/NAPP/SML Sample STATUS : Final Approved
Refer Lab/Hosp : Other Info :
Lab Address :AS 130, Block-H, R M Road, Kol: 157
DEPARTMENT OF CLINICAL BIOCHEMISTRY
Test Name Value Unit Bio Ref.Interval
Thyroid Stimulating Hormone (TSH) 1.16 uIU/mL 1D - 13D : 1.0 - 39.0
(Method:CLIA ) (Sample:Serum) 2W - 20W : 1.7 - 9.1
21W - 20Y : 0.7 - 6.4
Adults(more than 20Y) : 0.3 - 4.5
Pregnancy
First trimester : 0.3 - 4.5
Second trimester : 0.5 - 4.6
Third trimester : 0.8 - 5.2
Please clinically correlate. Partial reproduction of test reports is strictly prohibited.
The reports are strictly for the use of medical practitioners and are not medical diagnosis.
Comments:
Increased in:
Primary untreated hypothyroidism. Patient with hypothyroidism receiving insufficient thyroid hormone replacement therapy. Patients with Hashimoto thyroiditis, including
those will clinical hypothyroidism. Use of various drugs: Amphetamines (abuse), Iodine containing agents (e.g., Iopanoic acid, Ipodate, Amiodarone), Dopamine
antagonists (e.g., metoclopramide, domperidone, Chlorpromazine, Haloperidol).
Decrease in:
Toxic multinodular goiter. Autonomously functioning thyroid adenoma. Ophthalmopathy of euthyroid Graver disease, Thyroiditis, Extrathyroidal thyroid hormone source,
factitious, overreplacement of thyroid hormone in the treatment of hypothyroidism.
Sample: Inhouse Sample
*** End Of Report ***
Page 5 of 5
